- Home
- MATV vs RCKT Comparison
MATV vs RCKT Comparison
Compare MATV & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MATV | RCKT |
|---|---|---|
| Founded | 1995 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.9M | 394.2M |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MATV | RCKT |
|---|---|---|
| Price | $12.25 | $2.49 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $8.85 |
| AVG Volume (30 Days) | 425.4K | ★ 1.8M |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.30% | N/A |
| EPS Growth | N/A | ★ 26.37 |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | N/A |
| Revenue This Year | $1.75 | N/A |
| Revenue Next Year | $3.32 | $915.60 |
| P/E Ratio | ★ N/A | $3.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.07 | $2.50 |
| 52 Week High | $15.48 | $5.45 |
Technical Indicators
Market Signals| Indicator | MATV | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 57.20 | 27.55 |
| Support Level | $11.76 | N/A |
| Resistance Level | $12.74 | $4.02 |
| Average True Range (ATR) | 0.37 | 0.19 |
| MACD | -0.06 | -0.06 |
| Stochastic Oscillator | 71.21 | 3.86 |
Price Performance
Historical ComparisonAbout MATV Mativ Holdings Inc.
Mativ Holdings Inc is a leader in specialty materials, solving its customers' complex challenges by engineering bold, inventive solutions that connect, protect, and purify the world. The company operates in two segments, namely Filtration & advanced Materials, focused on filtration media and components, developed films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions (SAS), focused on tapes, labels, liners, specialty paper, packaging, and healthcare solutions.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.